Enhanced anticancer potential of Pd(II)-Thiosemicarbazone complexes: selectivity, mechanisms, and 3D models (2025)
- Authors:
- USP affiliated authors: ARAUJO NETO, JOÃO HONORATO DE - IQ ; ELLENA, JAVIER ALCIDES - IFSC
- Unidades: IQ; IFSC
- DOI: 10.3390/pharmaceutics17070829
- Subjects: NEOPLASIAS OVARIANAS; ANTINEOPLÁSICOS; CITOTOXINAS
- Keywords: Pd(II) complexes; Thiosemicarbazones; Cytotoxicity; Ovarian cancer
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Pharmaceutics
- ISSN: 1999-4923
- Volume/Número/Paginação/Ano: v. 17, n. 7, p. 829-1-829-23 + supplementary materials, July 2025
- Este periódico é de acesso aberto
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: gold
- Licença: cc-by
-
ABNT
LIMA, Mauro Almeida et al. Enhanced anticancer potential of Pd(II)-Thiosemicarbazone complexes: selectivity, mechanisms, and 3D models. Pharmaceutics, v. 17, n. 7, p. 829-1-829-23 + supplementary materials, 2025Tradução . . Disponível em: https://doi.org/10.3390/pharmaceutics17070829. Acesso em: 28 dez. 2025. -
APA
Lima, M. A., Teixeira, T., Fortaleza, D. B., Pereira, G. B. S., Akinyemi, A. O., Moraes, C. A. F., et al. (2025). Enhanced anticancer potential of Pd(II)-Thiosemicarbazone complexes: selectivity, mechanisms, and 3D models. Pharmaceutics, 17( 7), 829-1-829-23 + supplementary materials. doi:10.3390/pharmaceutics17070829 -
NLM
Lima MA, Teixeira T, Fortaleza DB, Pereira GBS, Akinyemi AO, Moraes CAF, Forim MR, Batista AA, Dutra J de L, de Araujo Neto JH, Ellena J, Rocha FV. Enhanced anticancer potential of Pd(II)-Thiosemicarbazone complexes: selectivity, mechanisms, and 3D models [Internet]. Pharmaceutics. 2025 ; 17( 7): 829-1-829-23 + supplementary materials.[citado 2025 dez. 28 ] Available from: https://doi.org/10.3390/pharmaceutics17070829 -
Vancouver
Lima MA, Teixeira T, Fortaleza DB, Pereira GBS, Akinyemi AO, Moraes CAF, Forim MR, Batista AA, Dutra J de L, de Araujo Neto JH, Ellena J, Rocha FV. Enhanced anticancer potential of Pd(II)-Thiosemicarbazone complexes: selectivity, mechanisms, and 3D models [Internet]. Pharmaceutics. 2025 ; 17( 7): 829-1-829-23 + supplementary materials.[citado 2025 dez. 28 ] Available from: https://doi.org/10.3390/pharmaceutics17070829 - New ruthenium complexes containing para-substituted benzoic acid: synthesis, characterization and cytotoxicity assays
- Structure and in vitro antimicrobial activity of sulfamethoxazole and sulfadiazine polyiodide salts
- Synthesis, characterization of europium(III) and terbium(III) complexes containing lawsone ligand and their interaction with DNA, HSA, and topoisomerases
- In vitro and in vivo studies of fluorescent Half-Sandwich Ru(II)/alizarin complexes
- Synthesis and crystal structure of a coordination polymer based on copper(II) and mixed ligands
- The role of terminal and bridge ligands in the molecular upconversion of lanthanide(III) 1D coordination polymers
- Palladium (II) complexes as inhibitors of cathepsin B and topoisomerase I beta: synthesis, characterization, and cytotoxicity
- New ruthenium complexes containing salicylic acid and derivatives induce triple-negative tumor cell death via the intrinsic apoptotic pathway
- It takes two to tango, part II: synthesis of A-ring functionalised quinones containing two redox-active centres with antitumour activities
- meso-Tetra-(4-pyridyl)porphyrin/palladium(II) complexes as anticancer agents
Informações sobre o DOI: 10.3390/pharmaceutics17070829 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
PROD037310_3257299.pdf | Direct link |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
